Controlled release formulations of Ranitidine
US5853756A · kind A · utility
10Cited by
2References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 1, 1995 |
| Grant date | Dec 29, 1998 |
| Priority date | — |
| Expiry date | Sep 1, 2015 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/5047
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides oral formulations of Ranitidine Hydrochloride in the form of coated tablets and capsules which produce controlled or regulated dissolution and release at a fairly uniform rate over long periods--as long as 12 to 24 hours--to maintain Ranitidine at desired levels above the MEC.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.